Remission of Refractory Ascites and Discontinuation of Hemodialysis after Additional Rituximab to Long-term Glucocorticoid Therapy in a Patient with TAFRO Syndrome.

about

Remission of Refractory Ascites and Discontinuation of Hemodialysis after Additional Rituximab to Long-term Glucocorticoid Therapy in a Patient with TAFRO Syndrome.

Item

http://www.wikidata.org/entity/Q50101690

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Remission of Refractory Ascite ...... a Patient with TAFRO Syndrome.

@en

Remission of Refractory Ascite ...... a Patient with TAFRO Syndrome.

@nl

type

Item

label

Remission of Refractory Ascite ...... a Patient with TAFRO Syndrome.

@en

Remission of Refractory Ascite ...... a Patient with TAFRO Syndrome.

@nl

prefLabel

Remission of Refractory Ascite ...... a Patient with TAFRO Syndrome.

@en

Remission of Refractory Ascite ...... a Patient with TAFRO Syndrome.

@nl

P1476

Remission of Refractory Ascite ...... a Patient with TAFRO Syndrome.

@en

P2093

Fukuo Kondo

http://www.w3.org/2001/XMLSchema#string

Hanako Tsurumi

http://www.w3.org/2001/XMLSchema#string

Kei Taniguchi

http://www.w3.org/2001/XMLSchema#string

Michito Nagura

http://www.w3.org/2001/XMLSchema#string

Nozomu Kurose

http://www.w3.org/2001/XMLSchema#string

Risa Iino

http://www.w3.org/2001/XMLSchema#string

Shigeru Shibata

http://www.w3.org/2001/XMLSchema#string

Shigeyuki Arai

http://www.w3.org/2001/XMLSchema#string

Shunya Uchida

http://www.w3.org/2001/XMLSchema#string

Tadashi Yamamoto

http://www.w3.org/2001/XMLSchema#string

P2860

Two Cases of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with High Serum Procalcitonin Levels, Including the First Case Complicated with Adrenal Hemorrhaging

[Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly].

Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?

[Efficacy of rituximab for TAFRO syndrome, a variant type of multicentric Castleman's disease].

Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report.

Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease.

Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.

Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy.

TAFRO syndrome showing cholangitis on liver biopsy.

Elevated serum interferon γ-induced protein 10 kDa is associated with TAFRO syndrome.

P304

1433-1438

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.2169/INTERNALMEDICINE.0116-17

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29321413

http://www.w3.org/2001/XMLSchema#string

P932

5995702

http://www.w3.org/2001/XMLSchema#string